TENX News and Press, Tenax Therapeutics Inc. From 09/14/23

Verbund AG ADR (OEZVY) is expected to report for Q2 2023 Adtran Networks SE (ADVOF) is expected to report for Q2 2023 OMV AG (OMVJF) is expected to report $1.66 for Q2 2023 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 Minim Inc (MINM) is expected to r...

DocuSign Inc. (DOCU) is expected to report $0.11 for Q2 2024 Firm Capital Property Trust Unit (FRMUF) is expected to report for Q1 2024 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Concrete Pumping Holdings Inc. (BBCP) is expected to report $0.16 for Q3 2023 ...

Tenax Therapeutics Inc. (TENX) is expected to report $-0.1 for Q2 2023

New U.S. patent provides intellectual property (IP) protection until December 2040, and may qualify for term extension beyond 2040 There are currently no FDA-approved treatments for PH-HFpEF, a condition affecting more than 1,600,000 North Americans, with estimates indicating a prevalence...

2023-05-31 11:16:41 ET Whether you’re trading penny stocks or higher-priced company shares, everyone wants to gain an edge. In the stock market today, there are plenty of catalysts to consider. Some are more apparent than others. Today we look at headlines and stock market news, one ...

Once granted, this patent will provide intellectual property protection until December 2040, and may qualify for additional U.S. patent term extension beyond 2040 There are currently no FDA approved treatments for PH-HFpEF, a condition affecting more than 1,600,000 North Americans, with e...

Company to prioritize the clinical development of TNX-103 (oral levosimendan) for the treatment of pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF) PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than...

Patent provides intellectual property protection until December 2040 PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030 There are currently no FDA approved treatments for PH-HFpEF Levosi...

2023-03-14 06:00:00 ET 3 Tips for Setting Realistic Penny Stocks Trading Goals Penny stocks can offer significant returns for those who are willing to invest the time and effort to research and understand them. However, it is essential to set realistic goals before investing in these ty...

2023-03-13 06:00:00 ET 3 Tips for Analyzing Penny Stocks After a Market Crash After a market crash, investors often seek out penny stocks as a potential source of quick profits. However, penny stocks can be extremely volatile, and analyzing them requires a different approach than an...